Barriers to ALS Therapy Development: Forging a Path Through with Dr. Shafeeq Ladha @EverythingALS
Barriers to ALS Therapy Development: Forging a Path Through with Dr. Shafeeq Ladha  @EverythingALS
Uploaded August 2025 | Updated September 2026, 2 weeks ago
For this Expert Talk, we were honored to host Dr. Shafeeq Ladha, one of the nation's leading voices in ALS research and care.

Dr. Ladha presented on the topic "Barriers to ALS Therapy Development: Forging a Path Through."

He discussed the disease's heterogeneity and the importance of biomarkers in clinical trials. The group discussion went on to explore various research approaches, including the use of neurofilament as a biomarker, the potential of AI in analyzing large datasets and the importance of improving clinical trial designs and preclinical models.

In addition, Dr. Ladha answered several questions at the end of the talk.

Related links:
Speech Study: everythingals.org/speechproject
The ALS Gene Carrier Study: everythingals.org/asymptomatic-study

About EverythingALS:
EverythingALS is a patient-focused nonprofit organization dedicated to accelerating the discovery of treatments and a cure for ALS through collaboration, innovation, and empowering patients and researchers.

Stay Connected:
► Website: everythingals.org
► Twitter: https://x.com/everything_als
► LinkedIn: / everythingals
► Facebook: / everythingals
► Subscribe for more Expert Talks: / everythingals

🔔 Subscribe to EverythingALS for expert discussions, research updates, and community support for ALS.

#ALS #Nutrition #EverythingALS #ALSResearch #Neuroscience #PatientCare
Barriers to ALS Therapy Development: Forging a Path Through with Dr. Shafeeq LadhaALS Expert Talk: Preserving nerve-muscle contacts to battle ALSInsights from a Phase 2B ALS StudyExpanded Access for Rare DiseasesALS Genetics: Lessons from familial ALS/FTD and ALS prevention by Dr.Mark Garret M.DAntisense Oligonucleotide Therapy for ALSPeters Innovations at AmazonA Multi-Target Approach to ALS30 years of ALS Genetics:  distinguishing Signal from Noise by Dr. Matthew HarmsThe Miami Framework forALS & RelatedNeurodegenerativeDisordersThe PREVAiLS Study: Pridopidine for the Treatment of ALSThe Morris ALS Principles
Everything ALS |

Barriers to ALS Therapy Development: Forging a Path Through with Dr. Shafeeq Ladha

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER